Delivery Order #SPE2DR26FMEM9

Pharmaceutical Delivery Order for Keytruda Awarded to DMS Pharmaceutical Group

This award represents a delivery order contract under the framework of a previously established indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a specialized healthcare solutions provider. The contract procures a specific quantity of Keytruda QLEX 395 MG, a critical pharmaceutical product used in cancer treatment. This procurement is significant for the agency's healthcare supply chain, ensuring timely access to vital medications that directly impact patient care within government healthcare facilities. The scope of the work includes the delivery of the pharmaceutical units to a designated location in Park Ridge, Illinois, over a brief, specified period. The delivery order was issued under the existing IDV contract, highlighting a streamlined procurement process aimed at efficient pharmaceutical distribution. This award was likely competitively bid through the umbrella IDV contract, consistent with standard federal procurement practices. The contract timeline is short-term, reflecting the nature of the delivery order within the broader, ongoing pharmaceutical procurement program.

Description

4571019965!KEYTRUDA QLEX 395 MG-4800 UNIT 2.4ML

View original record